Expertise in
22
conditions

Dr. Alexander C. Hu

Internal Medicine
Office
399 S Malpais Ln Ste 108, 
Flagstaff, AZ 
Accepting New Patients
Offers Telehealth
Before you request
Expertise in
22
conditions
Office
399 S Malpais Ln Ste 108, 
Flagstaff, AZ 

Overview

Alexander Hu is a primary care provider, practicing in Internal Medicine in Flagstaff, Arizona.

Dr. Hu is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Rhizomelic Pseudopolyarthritis, Gout, IgG4-Related Disease, and Light Chain Deposition Disease (LCDD).

He is actively involved in clinical research, participating in 5 clinical trials. Dr. Hu is currently accepting new patients.

Specialties

Internal Medicine

Hospital Affiliations

Yavapai Regional Medical Center
Verde Valley Medical Center
Summit Healthcare Regional Medical Center
Flagstaff Medical Center
Kingman Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EMI Health
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 22 Less Insurance Carriers -

Locations

Office
399 S Malpais Ln Ste 108, Flagstaff, AZ 86001

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain a Serum Uric Acid Response
A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Received Pegloticase Monotherapy But Did Not Maintain a Serum Uric Acid Response
Enrollment Status: Completed
Publish Date: June 27, 2024
Intervention Type: Drug, Biological
Study Drug: Pegloticase
Study Phase: Phase 4
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
7
conditions
Dr. Richard A. Adams
Internal Medicine
Expertise in
7
conditions
Dr. Richard A. Adams
Internal Medicine

Office

Cottonwood, AZ 
 (40.0 miles away)
928-634-4555
Languages Spoken:
English
See accepted insurances

Richard Adams is a primary care provider, practicing in Internal Medicine in Cottonwood, Arizona. Dr. Adams is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Anal Cancer, PIK3CA-Related Overgrowth Spectrum, and Lung Metastases.

Expertise in
72
conditions
Dr. Rajiv Jetly
Internal Medicine
Expertise in
72
conditions
Dr. Rajiv Jetly
Internal Medicine

Southwest ID & Medical Clinic LC

3235 N Windsong Dr, 
Prescott Valley, AZ 
 (56.4 miles away)
928-772-3340
Languages Spoken:
English
See accepted insurances

Rajiv Jetly is a primary care provider, practicing in Internal Medicine in Prescott Valley, Arizona. Dr. Jetly is highly rated in 72 conditions, according to our data. His clinical expertise encompasses Cirrhosis, Chronic Cough, Familial Combined Hyperlipidemia, and Xanthoma.

Expertise in
33
conditions
Dr. Michael J. Mortensen
Internal Medicine
Expertise in
33
conditions
Dr. Michael J. Mortensen
Internal Medicine
Before you request

Flagstaff Medical Center Specialty Clinic

1215 N Beaver St # 203, 
Flagstaff, AZ 
 (6.5 miles away)
928-773-2200
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Mortensen is a primary care provider, practicing in Internal Medicine in Flagstaff, Arizona. He has been practicing medicine for over 17 years. Dr. Mortensen is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Adrenal Insufficiency Pediatric, Hypothyroidism, Hyperthyroidism, Graves Disease, and Endoscopy. Dr. Mortensen is currently accepting new patients.

Frequently Asked Questions about Dr. Alexander C. Hu

How do I make an appointment with Dr. Alexander C. Hu?

You can book an appointment with Dr. Alexander C. Hu by calling their office at 480-443-8400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Alexander C. Hu a top-rated expert for Rhizomelic Pseudopolyarthritis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Alexander C. Hu is classified as an Distinguished expert for Rhizomelic Pseudopolyarthritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Alexander C. Hu specialize in?

While Dr. Alexander C. Hu is a Internal Medicine, they have specific expertise in Rhizomelic Pseudopolyarthritis, Gout, and IgG4-Related Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Alexander C. Hu accept my insurance?

Dr. Alexander C. Hu accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 480-443-8400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hu's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 13 Advanced Conditions
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile